Cargando…
P1483: EPELEUTON, A NOVEL SYNTHETIC SECOND GENERATION W-3 FATTY ACID, PROTECTS HUMANIZED SICKLE CELL MICE AGAINST HYPOXIA/REOXYGENATION ORGAN DAMAGE
Autores principales: | Federti, E., Matte’, A., Hamza, M., Lafferty, A., Coughlan, D., Weissbach, M., Bhatt, D. L., Riccardi, V., Perissinotto, R., Siciliano, A., Climax, J., Brugnara, C., De Franceschi, L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429060/ http://dx.doi.org/10.1097/01.HS9.0000848788.30039.63 |
Ejemplares similares
-
Effects of Epeleuton, a Novel Synthetic Second‐Generation n‐3 Fatty Acid, on Non‐Alcoholic Fatty Liver Disease, Triglycerides, Glycemic Control, and Cardiometabolic and Inflammatory Markers
por: Climax, John, et al.
Publicado: (2020) -
P1439: EPELEUTON, A NOVEL SYNTHETIC Ω-3 FATTY ACID, REDUCES ENDOTHELIAL ADHESION OF RED BLOOD CELLS FROM SICKLE CELL DISEASE PATIENTS UNDER PHYSIOLOGICAL FLOW CONDITIONS
por: Hamza, Moayed, et al.
Publicado: (2023) -
In Humanized Sickle Cell Mice, Imatinib Protects Against Sickle Cell–Related Injury
por: Federti, Enrica, et al.
Publicado: (2023) -
New Therapeutic Options for the Treatment of Sickle Cell Disease
por: Matte, Alessandro, et al.
Publicado: (2019) -
Hieronymus Fracastorius 1483—1553
por: Banerjee, A. K.
Publicado: (1988)